Cargando…

Tau Ubiquitination in Alzheimer's Disease

Paired helical filaments (PHFs) from the Alzheimer's disease (AD) brain are highly ubiquitinated and ubiquitination likely plays a vital role in tau filament formation. Whether tau ubiquitination is the causality or consequence of the disease in AD remains elusive. The following questions are w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Longfei, Jiang, Yanli, Wang, Jian-Zhi, Liu, Rong, Wang, Xiaochuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860969/ https://www.ncbi.nlm.nih.gov/pubmed/35211074 http://dx.doi.org/10.3389/fneur.2021.786353

Ejemplares similares

Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
por: Canepa, Elisa, et al.
Publicado: (2021)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Tau Pathology in Chronic Traumatic Encephalopathy and Alzheimer's Disease: Similarities and Differences
por: Katsumoto, Atsuko, et al.
Publicado: (2019)

Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study
por: Wang, Yan-Li, et al.
Publicado: (2021)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

Oxiracetam Offers Neuroprotection by Reducing Amyloid β-Induced Microglial Activation and Inflammation in Alzheimer's Disease
por: Zhang, Heng, et al.
Publicado: (2020)

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
por: Guedes, Joana R., et al.
Publicado: (2018)

Human Dental Pulp Stem Cells Display a Potential for Modeling Alzheimer Disease-Related Tau Modifications
por: Gazarian, Karlen, et al.
Publicado: (2021)

Tau PET With (18)F-THK-5351 Taiwan Patients With Familial Alzheimer's Disease With the APP p.D678H Mutation
por: Huang, Chin-Chang, et al.
Publicado: (2019)

Case report: Non-Alzheimer's disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET
por: Momota, Yuki, et al.
Publicado: (2022)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

Quantitative (18)F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients
por: Zhao, Qian, et al.
Publicado: (2019)

Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease
por: Puangmalai, Nicha, et al.
Publicado: (2022)

Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
por: Diez, Lisa, et al.
Publicado: (2020)

Targeting Tau to Treat Clinical Features of Huntington's Disease
por: Masnata, Maria, et al.
Publicado: (2020)

Tau Oligomers and Fibrils Exhibit Differential Patterns of Seeding and Association With RNA Binding Proteins
por: Jiang, Lulu, et al.
Publicado: (2020)

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease
por: Zeng, Kuan, et al.
Publicado: (2022)

Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
por: Oakley, Sebastian S., et al.
Publicado: (2020)

Post-Translational Modifications of BACE1 in Alzheimer's Disease
por: Wen, Wen, et al.
Publicado: (2022)

Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice
por: Zareba-Paslawska, Justyna, et al.
Publicado: (2021)

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
por: Alquezar, Carolina, et al.
Publicado: (2021)

Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us?
por: Houben, Sarah, et al.
Publicado: (2021)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Differences in treatment for Alzheimer's disease between urban and rural areas in China
por: Li, Bei, et al.
Publicado: (2022)

Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis
por: Wang, Xin-Chen, et al.
Publicado: (2022)

SIRT1 Deacetylates TET2 and Promotes Its Ubiquitination Degradation to Achieve Neuroprotection Against Parkinson's Disease
por: Li, Xuan, et al.
Publicado: (2021)

Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis
por: Zhang, Junjiao, et al.
Publicado: (2023)

Identification of the molecular subgroups in Alzheimer's disease by transcriptomic data
por: Li, He, et al.
Publicado: (2022)

Editorial: Tau Pathology in Neurological Disorders
por: Do Carmo, Sonia, et al.
Publicado: (2021)

Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
por: Duquette, Antoine, et al.
Publicado: (2021)

CSF p-tau as a potential cognition impairment biomarker in ALS
por: Gong, Zhongying, et al.
Publicado: (2022)

Alzheimer´s Disease in the Perspective of Neuroimmunology
por: Maccioni, Ricardo B., et al.
Publicado: (2018)

USP10 deubiquitinates Tau, mediating its aggregation
por: Wei, Zhen, et al.
Publicado: (2022)

Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
por: Shamir, Dov B., et al.
Publicado: (2020)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
por: Valencia, Antonio, et al.
Publicado: (2021)

24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
por: Björkhem, Ingemar, et al.
Publicado: (2018)

Corpus Callosum Radiomics-Based Classification Model in Alzheimer's Disease: A Case-Control Study
por: Feng, Qi, et al.
Publicado: (2018)

The clinical correlation between Alzheimer's disease and epilepsy
por: Zhang, Dandan, et al.
Publicado: (2022)

Cellular Biology of Tau Diversity and Pathogenic Conformers
por: Kang, Sang-Gyun, et al.
Publicado: (2020)

Alterations in Tau Metabolism in ALS and ALS-FTSD
por: Strong, Michael J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qndllie0i1bbkbugm7eoue601l